| Discovery of a Selective TC-PTP Degrader for Cancer Immunotherapy J Miao, J Dong, Y Miao, Y Bai, Z Qu, BA Jassim, B Huang, Q Nguyen, ... Chemical Science, 2023 | 2 | 2023 |
| Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy Z Qu, Y Bai, J Dong, Z Zhang, B Huang, Y Miao, AW Tao, PS Low, ... Cancer Research 84 (6_Supplement), 4505-4505, 2024 | | 2024 |
| Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment F Zhang, B Huang, SM Utturkar, W Luo, G Cresswell, SA Herr, S Zheng, ... Frontiers in Immunology 15, 1354735, 2024 | | 2024 |
| Dual targeting of tumor cells and cancer associated fibroblasts enhances CAR T efficacy in solid tumors B Huang, S Zheng, H Chu, R Mukkamala, SK Bowroju, Y Singh, ... Cancer Research 83 (7_Supplement), 4099-4099, 2023 | | 2023 |
| Design of bispecific adapters for universal CAR T cell therapies of solid tumors S Zheng, B Huang, Y Singh, H Chu, SK Bowroju, MS Bari, M Srinivasarao, ... Cancer Research 83 (7_Supplement), 1787-1787, 2023 | | 2023 |
